SCHEMBL2018103

SCHEMBL2018103

CCc1ccc(SCl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
ATM Q13315 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
CYP2A6 P11509 1/20 0.41
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
IDO1 P14902 2/20 0.40
MGLL Q99685 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CA2 P00918 1/20 0.38
POLB P06746 1/20 0.38
DDB1 Q16531 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2024250 0.80 LPL (0.45) L3MBTL1LPLLIPGKDM4EMGLL
SCHEMBL775853 0.78 TP53 (0.48) TP53ATMTSHRMAPK1TDP1
SCHEMBL18159470 0.78 TP53 (0.48) TP53ATMTSHRMAPK1TDP1
SCHEMBL576175 0.78 TP53 (0.48) TP53ATMTSHRMAPK1TDP1
SCHEMBL2022281 0.77 CA2 (0.48) TP53LPLLIPGSMN1; SMN2KDM4E
SCHEMBL11250295 0.76 NR1H2 (0.32) TSHRMAPK1
SCHEMBL36295 0.76 TP53 (0.67) TP53ATMTSHRMAPK1TDP1
SCHEMBL257109 0.76 MEN1 (0.55) TP53ATMSMN1; SMN2KDM4EMEN1
SCHEMBL10012406 0.76 TP53 (0.46) TP53ATMTSHRMAPK1TDP1
SCHEMBL13242335 0.74 SLC6A4 (0.57) TP53TAAR1CYP2A6LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3094325-B1 HETEROARYLS AND USES THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2021-10-13 EP disclosed
US-20110160488-A1 Fluorination Processes with Arylsulfur Halotetrafluorides I M &T RESEARCH, INC. (US) 2011-06-30 US disclosed
WO-2009114409-A2 FLUORINATION PROCESSES WITH ARYLSULFUR HALOTETRAFLUORIDES IM & T RESEARCH, INC. (US) 2009-09-17 WO disclosed
US-3963683-A Rubber formulations containing vulcanization inhibiting thioformamidine compounds UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160488-A1 Fluorination Processes with Arylsulfur Halotetrafluorides CYP2F1, PFAS, CYP4F2 TP53 3229/4885ATM 3023/4885TSHR 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.